New promoter takes over, 99% capital cut proposed, auditor replaced

Auditor Resigned MidtermManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹8.85

prior close

₹8.41

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-5.6% vs market

Other Textile Products peers, median of 182sector+0.2%-5.2% vs sector

On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 5.2 pts less than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+0.6-5.6+0.2-5.2

Next day

-9.7+0.9-10.7-0.2-9.6

-14.1-0.2-13.9-0.4-13.7

-18.4-0.9-17.5-0.7-17.7

-22.5-0.5-22.0-1.2-21.3

-26.3+0.8-27.1-0.6-25.7

-33.4-0.0-33.4-0.9-32.5

15d

-14.0+3.9-18.0-0.7-13.4

+26.4+4.8+21.6-0.9+27.4

+64.9+5.1+59.7-0.6+65.5

+1.1-1.6+2.8-5.7+6.8

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 182Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Oxford Industries has new promoter Mr. Saroj Kumar Choudhary with 46.46% stake via open offer. He is now MD and also appointed CFO. Statutory auditor PAMS and Associates resigned mid-term due to geographic issues; Lipika and Associates proposed as new auditor for 5 years. Board proposes 99% capital reduction due to accumulated losses, shifting registered office to Orissa, and adding healthcare and pharmaceutical businesses. Items need shareholder approval.

Likely market impact

Major change of control with 99% capital cut due to losses and shift into healthcare. Awaiting shareholder approval.